113 related articles for article (PubMed ID: 3899153)
1. Prednisolone protein binding in renal transplant patients.
Reece PA; Disney AP; Stafford I; Shastry JC
Br J Clin Pharmacol; 1985 Aug; 20(2):159-62. PubMed ID: 3899153
[TBL] [Abstract][Full Text] [Related]
2. Endogenous and exogenous glucocorticoids in cushingoid patients.
Benet LZ; Frey FJ; Amend WJ; Lozada F; Frey BM
Drug Intell Clin Pharm; 1982 Nov; 16(11):863-8. PubMed ID: 6756849
[TBL] [Abstract][Full Text] [Related]
3. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
Frey FJ; Frey BM
Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
[TBL] [Abstract][Full Text] [Related]
4. Correlation and prediction of phenytoin protein binding using standard laboratory parameters in patients after renal transplantation.
Monaghan MS; Marx MA; Olsen KM; Turner PD; Bergman KL
Ther Drug Monit; 2001 Jun; 23(3):263-7. PubMed ID: 11360036
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
[TBL] [Abstract][Full Text] [Related]
6. The effect of prednisone and hydrocortisone on the plasma protein binding of prednisolone in man.
Legler UF; Benet LZ
Eur J Clin Pharmacol; 1986; 30(1):51-5. PubMed ID: 3709632
[TBL] [Abstract][Full Text] [Related]
7. Prednisolone withdrawal after 2 years in renal transplant patients receiving only this form of immunosuppression.
Naik RB; Abdeen H; English J; Chakraborty J; Slapak M; Lee HA
Transplant Proc; 1979 Mar; 11(1):39-44. PubMed ID: 377662
[No Abstract] [Full Text] [Related]
8. Prednisolone disposition and protein binding in oral contraceptive users.
Boekenoogen SJ; Szefler SJ; Jusko WJ
J Clin Endocrinol Metab; 1983 Apr; 56(4):702-9. PubMed ID: 6833459
[TBL] [Abstract][Full Text] [Related]
9. Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipients.
Bergmann TK; Isbel NM; Ostini R; Barraclough KA; Campbell SB; McWhinney BC; Inder WJ; Russell A; Staatz CE
Clin Drug Investig; 2015 Nov; 35(11):743-50. PubMed ID: 26403249
[TBL] [Abstract][Full Text] [Related]
10. Serious renal transplant rejection and adrenal hypofunction after gradual withdrawal of prednisolone two years after transplantation.
Naik RB; Chakraborty J; English J; Marks V; Slapak M; Lee HA
Br Med J; 1980 Jun; 280(6228):1337-40. PubMed ID: 6992931
[TBL] [Abstract][Full Text] [Related]
11. Nonlinear plasma protein binding and haemodialysis clearance of prednisolone.
Frey FJ; Gambertoglio JG; Frey BM; Benet LZ; Amend WJ
Eur J Clin Pharmacol; 1982; 23(1):65-74. PubMed ID: 6751835
[TBL] [Abstract][Full Text] [Related]
12. The nonlinear pharmacokinetics of prednisone and prednisolone. II. Plasma protein binding of prednisone and prednisolone in rabbit and human plasma.
Ferry JJ; Wagner JG
Biopharm Drug Dispos; 1987; 8(3):261-72. PubMed ID: 3593903
[TBL] [Abstract][Full Text] [Related]
13. The binding of prednisolone in human serum and to recrystallized human albumin in vitro.
Steele WH; Hawksworth GM; Barber HE
Br J Clin Pharmacol; 1982 Nov; 14(5):667-72. PubMed ID: 7138746
[TBL] [Abstract][Full Text] [Related]
14. Predicting etoposide toxicity: relationship to organ function and protein binding.
Joel SP; Shah R; Clark PI; Slevin ML
J Clin Oncol; 1996 Jan; 14(1):257-67. PubMed ID: 8558207
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.
Atcheson BA; Taylor PJ; Mudge DW; Johnson DW; Hawley CM; Campbell SB; Isbel NM; Pillans PI; Tett SE
Br J Clin Pharmacol; 2005 Mar; 59(3):271-80. PubMed ID: 15752372
[TBL] [Abstract][Full Text] [Related]
16. The separation of unbound prednisolone in plasma by centrifugal ultrafiltration.
Miller PF; Wheeldon J; Brocklebank JT
J Pharm Pharmacol; 1987 Nov; 39(11):939-41. PubMed ID: 2892921
[TBL] [Abstract][Full Text] [Related]
17. Absorption of enteric and non-enteric coated prednisolone tablets.
Hulme B; James VH; Rault R
Br J Clin Pharmacol; 1975 Aug; 2(4):317-20. PubMed ID: 1233990
[TBL] [Abstract][Full Text] [Related]
18. A practical limited sampling strategy to predict free prednisolone exposure and glycemia in kidney transplant recipients.
Yates CJ; Barraclough KA; McWhinney BC; Ungerer JP; Fullinfaw RO; Colman PG; Fourlanos S; Cohney SJ
Ther Drug Monit; 2014 Feb; 36(1):18-23. PubMed ID: 24335760
[TBL] [Abstract][Full Text] [Related]
19. Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion.
Frey BM; Frey FJ
Br J Clin Pharmacol; 1982 Feb; 13(2):245-9. PubMed ID: 6800390
[No Abstract] [Full Text] [Related]
20. Alterations in prednisolone disposition as a result of time of administration, gender and dose.
Meffin PJ; Brooks PM; Sallustio BC
Br J Clin Pharmacol; 1984 Apr; 17(4):395-404. PubMed ID: 6721985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
